KAMADA » INVESTORS » NEWS & EVENTS

NEWS & EVENTS

Latest News

Kamada Submits Proposed Phase 3 Protocol to FDA for Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency Disease

Jul. 20, 2017

Kamada announced that the Company has submitted to the U.S. Food and Drug Administration (FDA) for review a proposed pivotal Phase 3 protocol for its proprietary inhaled Alpha-1 Antitrypsin (AAT) therapy (Inhaled AAT) for the treatment of Alpha-1 Antitrypsin Deficiency (AATD).  

Kamada Announces Withdrawal of European Marketing Authorization Application for Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency Disease

Jun. 27, 2017

Kamada announced that the Company has withdrawn the Marketing Authorization Application (MAA) for its proprietary inhaled Alpha-1 Antitrypsin (AAT) therapy for the treatment of Alpha-1 Antitrypsin Deficiency (AATD) with the European Medicines Agency (EMA).


Upcoming Events

Kamada to participate in ATS conference, Washington DC, 2017

May. 19-24, 2017 / Washington DC, USA

The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.

Kamada to participate in ADA (American Diabetes Association) 77th Scientific Sessions

Jun. 9-13, 2017 / San Diego, California

This program offers a unique opportunity for early career endocrinologists who treat diabetes and its complications to take advantage of small-group learning and networking experiences such as:

* Peer-to-peer engagement during small-group breakout sessions June 8-9.

* Opportunities to meet senior scientists/clinicians during receptions and “Lunch with the Expert”      sessions.

* Support in navigating the primary meeting, the 77th Scientific Sessions with ongoing activities        and a private lounge. 

 


Past Event

Kamada to participate in BIO International Convention, San Diego USA

Jun. 19-22, 2017 / San Diego, Ca, USA

The BIO International Convention (BIO) attracts 16,000 biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. We bring together a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.